Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.66 |
| ▸ | NPY4R | P50391 | 8/20 | 0.66 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.66 |
| ▸ | NPY1R | P25929 | 6/20 | 0.66 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.60 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.60 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.60 |
| ▸ | CALCR | P30988 | 2/20 | 0.60 |
| ▸ | MC4R | P32245 | 2/20 | 0.60 |
| ▸ | MC5R | P33032 | 2/20 | 0.60 |
| ▸ | MC3R | P41968 | 2/20 | 0.60 |
| ▸ | MC1R | Q01726 | 2/20 | 0.60 |
| ▸ | REN | P00797 | 3/20 | 0.59 |
| ▸ | TFPI | P10646 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18872896 | 0.87 | AGTR1 (0.68) | NPY2RNPY4RNPY5RNPY1RAGTR1 | |
| SCHEMBL29358935 | 0.86 | TFPI (0.64) | NPY2RNPY4RNPY5RNPY1RREN | |
| SCHEMBL18872894 | 0.86 | AGTR1 (0.68) | NPY2RNPY4RNPY5RNPY1RAGTR1 | |
| Apidaecin Ia SCHEMBL29458103 | 0.86 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1RAGTR1 | |
| SCHEMBL13197592 | 0.85 | AGTR1 (0.66) | NPY2RNPY4RNPY5RNPY1RAGTR1 | |
| Trv-120027 SCHEMBL29382211 | 0.84 | AGTR1 (0.73) | NPY2RNPY4RNPY5RNPY1RAGTR1 | |
| Apidaecin SCHEMBL29380656 | 0.83 | NPY4R (0.67) | NPY2RNPY4RNPY5RNPY1RAGTR1 | |
| SCHEMBL31519869 | 0.83 | OPRD1 (0.64) | — | |
| SCHEMBL4331434 | 0.83 | NPY2R (0.75) | NPY2RNPY4RNPY5RNPY1RRAMP3 | |
| SCHEMBL30432597 | 0.83 | NPY2R (0.67) | NPY2RNPY4RNPY5RNPY1RRAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686756-A1 | METHOD FOR TARGETING AND MAPPING OF ESSENTIAL PHAGE GENES AND USES THEREFOR | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2026-02-04 | — | — | EP | claimed |
| WO-2025106551-A1 | HYDROGEL COMPOSITIONS COMPRISING SYNERGISTIC ANTIMICROBIAL PEPTIDES (AMPS) AND METHODS OF MAKING SAME | ROWAN UNIVERSITY (US) | 2025-05-22 | — | — | WO | claimed |
| US-20240189490-A1 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2024-06-13 | — | — | US | claimed |
| EP-4319849-A1 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | The Children's Hospital of Philadelphia (US) | 2024-02-14 | — | — | EP | claimed |
| US-20240035036-A1 | FlmG-Dependent Soluble Protein O-Glycosylation Systems In Bacteria | UNIVERSITE DE GENEVE (CH) | 2024-02-01 | — | — | US | claimed |
| EP-4229203-A2 | FLMG-DEPENDENT SOLUBLE PROTEIN O-GLYCOSYLATION SYSTEMS IN BACTERIA | Université de Genève (CH) | 2023-08-23 | — | — | EP | claimed |
| WO-2023141679-A1 | DIMERS AND USES THEREFOR | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2023-08-03 | — | — | WO | claimed |
| WO-2022217071-A1 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2022-10-13 | — | — | WO | claimed |
| EP-4003269-A1 | HYBRID MINERAL-ORGANIC COMPLEX, AND USE THEREOF FOR MAINTAINING THE MICROBIOLOGICAL BALANCE OF THE SKIN AND/OR OF A COSMETIC AND/OR DERMOPHARMACEUTICAL COMPOSITION | Bionuclei (FR) | 2022-06-01 | — | — | EP | claimed |
| WO-2022079220-A2 | FLMG-DEPENDENT SOLUBLE PROTEIN O-GLYCOSYLATION SYSTEMS IN BACTERIA | UNIVERSITÉ DE GENÈVE (CH) | 2022-04-21 | — | — | WO | claimed |
| WO-2022058330-A1 | AN ANTIMICROBIAL PEPTIDE (AMP) OR ANALOGUE THEREOF COMPRISING AT LEAST ONE PEPTIDOMIMETIC EXTENSION FOR USE AS AN ANTIMICROBIAL COMPOUND AGAINST AN INFECTIOUS DISEASE | Københavns Universitet (DK) | 2022-03-24 | — | — | WO | claimed |
| CN-121992029-A | Method for inducing antibacterial peptide to express resistance to yellow dragon disease by transforming citrus with Drosophila Drosocin gene | 西南大学 | 2026-05-08 | — | — | CN | disclosed |
| CN-121992029-A | Method for inducing antibacterial peptide to express resistance to yellow dragon disease by transforming citrus with Drosophila Drosocin gene | 西南大学 | 2026-05-08 | — | — | CN | disclosed |
| EP-4709357-A2 | EXTRACELLULAR VESICLE COMPOSITIONS AND PREPARATION | Virginia Tech Intellectual Properties, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4686756-A1 | METHOD FOR TARGETING AND MAPPING OF ESSENTIAL PHAGE GENES AND USES THEREFOR | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2026-02-04 | — | — | EP | disclosed |
| US-11350648-B2 | Compositions and related methods for agriculture | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| EP-4003269-A1 | HYBRID MINERAL-ORGANIC COMPLEX, AND USE THEREOF FOR MAINTAINING THE MICROBIOLOGICAL BALANCE OF THE SKIN AND/OR OF A COSMETIC AND/OR DERMOPHARMACEUTICAL COMPOSITION | Bionuclei (FR) | 2022-06-01 | — | — | EP | disclosed |
| WO-2022079220-A2 | FLMG-DEPENDENT SOLUBLE PROTEIN O-GLYCOSYLATION SYSTEMS IN BACTERIA | UNIVERSITÉ DE GENÈVE (CH) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022069996-A1 | BIODEGRADABLE POLYMER AND SOLVENT COMPOSITIONS AND SYSTEMS FOR EXTENDED STORAGE AND DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS | TOLMAR INTERNATIONAL LIMITED (IE) | 2022-04-07 | — | — | WO | disclosed |
| WO-2022058330-A1 | AN ANTIMICROBIAL PEPTIDE (AMP) OR ANALOGUE THEREOF COMPRISING AT LEAST ONE PEPTIDOMIMETIC EXTENSION FOR USE AS AN ANTIMICROBIAL COMPOUND AGAINST AN INFECTIOUS DISEASE | Københavns Universitet (DK) | 2022-03-24 | — | — | WO | disclosed |